Originally developed by Metabolic Pharmaceuticals in Australia during the 1990s, this synthetic peptide was designed to harness growth hormones fat-mobilizing properties while avoiding the metabolic complications associated with full-length GH therapy
For BPC-157 specifically, "BPC-157" returns the working corpus
TUNEL Assay Apoptosis of rats gastric epithelial cells was evaluated using TUNEL apoptosis assay kit (Vazyme, Nanjing, Jiangsu, China) according to the manufacturers instructions
Every reference below is publicly available, peer-reviewed
Shorter stability post-reconstitution: The peptide should be refrigerated and used promptly to preserve potency
While human clinical trials remain the gold standard, the breadth and consistency of animal research offers valuable insights into what users might expect